Content
67%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
A well-structured, actionable annotation workflow with clear phasing and robust fallback chains. The main weaknesses are conceptual prose that restates known genetics reasoning and the absence of executable code examples or externalized reference material.
Suggestions
Trim the Pathogenicity Reasoning Framework and KEY PRINCIPLES to operational decision rules, removing explanation of basic conservation and frequency concepts Claude already knows.
Add at least one copy-paste-ready example showing a full annotation call sequence and result handling for a representative variant.
Move the detailed per-tool parameter reference and annotator string recipes into a separate references file, keeping SKILL.md as a lean overview pointing to it.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Mostly efficient with well-organized tool-call reference, but the prose Pathogenicity Reasoning Framework and KEY PRINCIPLES re-explain concepts (conservation, population frequency logic) Claude already knows, adding length without new operational detail. | 3 / 5 |
Actionability | Provides concrete tool names with parameter signatures and formats (e.g., gnomad_get_variant 'chrom-pos-ref-alt' hg38, CADD without 'chr' prefix), but offers no executable code examples and the report template is structural pseudocode. | 4 / 5 |
Workflow Clarity | A clear phased sequence (Phase 0–5 plus Synthesis) with explicit fallback chains for each tool failure; checkpoints are implicit via T1–T4 grading rather than explicit validate-and-retry steps, so it sits just below 5. | 4 / 5 |
Progressive Disclosure | Well-organized single-file structure with clear section headers and a self-contained scope; no bundle files exist to split out, and the one-level layout navigates well, though some API-reference detail could be externalized to a reference file. | 4 / 5 |
Total | 15 / 20 Passed |